Endocrinology

Jan 09 2025 104 ep. 77

Copy RSS

Subscribe on Podcast Addict

A Global Health Crisis

Guest: Donna Ryan, MD Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning activities will provide tips and t

Diagnosing Obesity: Beyond BMI

Guest: Walmir Coutinho, MD Guest: Charles P. Vega, MD Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning

Breaking the Bias: Addressing Stigma in Obesity Care

Guest: Charles P. Vega, MD Guest: Walmir Coutinho, MD Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning

Pharmacotherapy in Obesity: Current and Emerging Options

Guest: Donna Ryan, MD Guest: Andreea Ciudin, MD, PhD Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning

Personalized Obesity Management: A Comprehensive Approach

Guest: Donna Ryan, MD Guest: Andreea Ciudin, MD, PhD Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning

The Power of Teamwork: Multidisciplinary Obesity Care

Guest: Andreea Ciudin, MD, PhD Guest: Marta Comas Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning act

The Power of Shared Decision-Making in Obesity Care

Guest: Charles P. Vega, MD Obesity is a chronic, progressive disease, and in 2022, it affected nearly half of all adults worldwide, making it a global health crisis. This reinforces the importance of having sufficient, appropriate strategies available for healthcare professionals so they can optimize patient outcomes. Our series of micro learning activities will provide tips

Cardiorenal Collaboration: Optimizing Multidisciplinary Care in the CvRM Patient

Host: Raymond Townsend, MD Guest: Melissa Magwire, RN, MSN, CDE Guest: Michael Weber, MD The outcomes of large clinical trials such as EMPA-REG have demonstrated that SGLT2 inhibitors are effective, but they do more than lower blood sugar and improve A1c. Similar to statins a long time ago, SGLT2 inhibitors offer many advantages for patients with potential atherosclerot

ns-MRAs and Biomarkers: The NT-proBNP Connection

Guest: Muthiah Vaduganathan, MD, MPH Guest: Orly Vardeny, MD Discover the transformative potential of nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs) in optimizing care for patients with the Cardiovascular-Kidney-Metabolic syndrome. Emerging data presented at EASD, HFSA, ASN and AHA, highlight their ability to improve cardiorenal outcomes in the spectrum of t

Elevating HF Care With ns-MRAs: The Future Is Now

Guest: Orly Vardeny, MD Guest: Muthiah Vaduganathan, MD, MPH Discover the transformative potential of nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs) in optimizing care for patients with the Cardiovascular-Kidney-Metabolic syndrome. Emerging data presented at EASD, HFSA, ASN and AHA, highlight their ability to improve cardiorenal outcomes in the spectrum of t